KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Royalty Pharma (RPRX) Shares Outstanding (Weighted Average) (2020 - 2025)

Royalty Pharma (RPRX) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $429.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 4.1% to $429.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $429.8 million through Dec 2025, down 4.1% year-over-year, with the annual reading at $429.8 million for FY2025, 4.1% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $429.8 million in Q4 2025 for Royalty Pharma, roughly flat from $431.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $449.8 million in Q2 2024 to a low of $389.8 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $434.7 million across 5 years, with a median of $436.7 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 15.74% in 2021 and later fell 5.85% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $414.8 million in 2021, then rose by 5.59% to $438.0 million in 2022, then increased by 2.2% to $447.6 million in 2023, then increased by 0.13% to $448.2 million in 2024, then fell by 4.1% to $429.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for RPRX at $429.8 million in Q4 2025, $431.9 million in Q3 2025, and $423.5 million in Q2 2025.